- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prostate cancer
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 637KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 188KB)
Abiraterone and methylprednisolone – March 2022
Abiraterone and methylprednisolone: Pack containing 120 tablets abiraterone (as acetate) 125 mg and 60 tablets methylprednisolone 4 mg; Yonsa® MPRED
Last updated
15 July 2022